Navigation Links
PLC Systems Reports Fourth Quarter and Full Year 2011 Results
Date:3/30/2012

al milestones in the past few months, including the following:

  • We began our U.S. pivotal trial of RenalGuard and successfully enrolled our first patients, following receipt of final approval from the U.S. Food & Drug Administration of our adaptive trial design
  • We announced the path to approval for RenalGuard in Japan, arguably the second largest CIN treatment market worldwide, with the initial completion of a successful two patient safety trial
  • We recently announced approval to market RenalGuard in Israel, and appointed a distributor there, A.M.I. Technologies, Ltd.
  • Results from the investigator-sponsored MYTHOS clinical trial of RenalGuard were published in the peer-reviewed JACC-Cardiovascular Interventions
  • Results from PLC's pilot trial of RenalGuard were published in the peer-reviewed International Journal of Cardiology
  • RenalGuard was featured in a luncheon session at the important TCT conference in November and
  • We secured new patents to continue to strengthen our intellectual property position.
  • These developments help increase visibility for PLC and RenalGuard worldwide, and are critical to our effort to increase sales and adoption for RenalGuard in Europe and other countries where it is on the market."

    Mr. Tauscher added, "As we move through 2012, our confidence in the potential of RenalGuard as a valuable and targeted technology that addresses a large, unmet medical need worldwide continues to increase.  Our progress in aligning PLC with significant distributors who can bring RenalGuard to leading practitioners in key markets will help establish RenalGuard as a 'best practice'.  At the same time, we are very pleased by the launch of our clinical trial United States, and we expect to provide a more detailed update on our progress in the next few months."

    He concluded, "Thus, in 2012, we are focused on achieving the following milestones:


    '/>"/>
    SOURCE PLC Systems Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
    2. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
    3. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
    4. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
    5. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
    6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
    7. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
    8. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
    9. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
    10. PLC Systems Reports Fourth Quarter 2007 Results
    11. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... 3, 2015  VirtualScopics, Inc. (NASDAQ: VSCP ... solutions, announced today, they are collaborating with a ... philanthropic, epidemiology study partnering with the Ministry of ... has teamed up with a cardiac sonographer to ... results will be used to identify children with ...
    (Date:9/3/2015)... SEATTLE , Sept. 3, 2015  Omeros Corporation ... filed patent infringement lawsuits against Par Pharmaceutical, Inc. and ... the U.S. District Court for the District of ... District Court for the District of Delaware ... Act for Par,s infringement of three Omeros patents, U.S. ...
    (Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hs5hvr/investigation ... "Investigation Report on China Tamsulosin Market, 2010-2019" ... with other a1- adrenergic receptor blockers, tamsulosin hydrochloride ... risk of urinary tract infections and therefore is ... in 1993 in Japan , ...
    Breaking Medicine Technology:VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4China Tamsulosin Market Investigation Report 2015 2
    ... Holdings, Inc. (NYSE and SIX: ZMH), a global leader ... in the 2011 Morgan Stanley Global Healthcare Unplugged Conference ... September 13, 2011, at 9:10 a.m. Eastern Time. ... be accessed via Zimmer,s Investor Relations website at ...
    ... Sept. 1, 2011 Hill-Rom Holdings, Inc., (NYSE: ... management presentation at the Morgan Stanley Global Healthcare Conference ... 8:35 a.m. ET. You are invited to ... at http://ir.hill-rom.com/events.cfm or access it directly at ...
    Cached Medicine Technology:Zimmer Holdings to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference 2
    (Date:9/3/2015)... , ... September 03, 2015 , ... William Mattar Law ... Mattar, Esq. believes this does not stop at any certain demographic or segment of ... newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The closed captioning will ...
    (Date:9/3/2015)... ... 03, 2015 , ... Topical BioMedics, Inc., hosted Amsterdam resident ... six-month, 10,000 mile journey from Santiago, Chile to Times Square and then Rhinebeck, ... Las Americas” project—Max crossed six countries in 168 days on his 39-year-old Moto ...
    (Date:9/3/2015)... ... September 03, 2015 , ... ... to be situated at 4400 Columbine Drive in Bellingham, Washington. Silverado Bellingham, a ... has been carefully designed to serve up to 80 people living with Alzheimer’s, ...
    (Date:9/3/2015)... ... September 03, 2015 , ... RealtyShares ... connecting accredited and institutional investors to real estate investment opportunities nationwide, today announced ... demand from both investors and sponsoring real estate companies. , These ...
    (Date:9/3/2015)... ... September 03, 2015 , ... For ... in its Annual Inc. 5000 list of fastest-growing private companies in America. ... fraction of the nation's companies have demonstrated such remarkably consistent high growth, particularly ...
    Breaking Medicine News(10 mins):Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2
    ... lazy eye) need only wear an eye patch for three ... vision, say researchers in a study published on bmj.com ... to several years, which is often recommended, is almost certainly ... the vision pathways between the eyes and the brain, which ...
    ... Novavax Inc.,(Nasdaq: NVAX ) today announced that Dr. ... corporate overview and highlight recent,developments at the 2007 UBS ... 9:30 a.m. Eastern Time at the Grand Hyatt Hotel ... live web cast of Novavax,s presentation will be,available through ...
    ... third annual Researchers, Night is to provide researchers who have ... their often acclaimed research to the general public. About 10,000 ... evening will be Health and Technology. Research on display is ... and CERN. , The festive ,Lakeside Zurich, event will take ...
    ... One of the Largest PPO Dental Networks in The United ... Dependents ... Area, NEW YORK, Sept. 14 The Guardian Life ... voluntary,benefits for small and midsize business, today announced that its ...
    ... 165 ... 36 Medical Groups, CHICAGO and PITTSBURGH, Sept. 14 ... connectivity and,information solutions that physicians use to improve healthcare, announced,today ... its Electronic Health Record (EHR) provider for its primary,care network. ...
    ... conference,focusing on women and neurological diseases - and staffed ... take place from 8 a.m. - 1,p.m., Saturday, Sept. ... Rd. The conference will focus on coping with ... disease, dementia and,stroke. The woman-to-woman program will include ...
    Cached Medicine News:Health News:No need for children with lazy eye to wear patches all day 2Health News:Guardian's Dental Network Experiences Double-Digit Growth 2Health News:Guardian's Dental Network Experiences Double-Digit Growth 3Health News:West Penn Allegheny Health System Selects Electronic Health Record From Allscripts 2Health News:West Penn Allegheny Health System Selects Electronic Health Record From Allscripts 3Health News:West Penn Allegheny Health System Selects Electronic Health Record From Allscripts 4
    ... and Maximum ACT introducers represent the ... hemostasis introducers in the world. They ... introducers for use in interventional cardiology ... stenting, atherectomy, temporary pacing, endomyocardial biopsies, ...
    ... hemostasis introducers provide outstanding insertion ... dilator-to-sheath transitions, high kink resistance ... dual layer sheath cannula provides ... works with an extra strong ...
    Bx VELOCITY Coronary Stent with HEPACOAT...
    A steerable diagnostic catheter with optimal maneuverability...
    Medicine Products: